We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Events

15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024
25 Apr 2024 - 27 Apr 2024

New Minimally Invasive Cancer Diagnostic Device Eavesdrops On Cells’ Conversations

By LabMedica International staff writers
Posted on 26 Oct 2023
Print article
Image: The new technology could lead to quick, minimally invasive cancer diagnoses (Photo courtesy of American Chemical Society)
Image: The new technology could lead to quick, minimally invasive cancer diagnoses (Photo courtesy of American Chemical Society)

For a long time, scientists have understood that RNA (ribonucleic acid) serves as an internal messenger within cells, taking DNA's instructions to help the cells produce proteins. However, a recent discovery shows that specific kinds of RNA, termed "extracellular RNA" or exRNA, actually leave the cell. These exRNAs are enclosed in tiny carrier structures and travel through bodily fluids, acting like tiny informational messages in bottles. These exRNAs are incredibly valuable as they could hold early indicators for diseases like cancer, heart disease, and HIV. Detecting diseases via exRNA could be quicker, more effective, and cheaper than current techniques. The challenge, however, has been separating and interpreting these exRNAs, as existing methods like advanced filters and centrifuges haven't been very successful.

A team of scientists at the University of Notre Dame (Notre Dame, IN, USA) has created a groundbreaking device that uses an ingenious approach to 'eavesdrop' on cells’ conversations. This palm-sized device combines existing technologies and employs a mix of pH levels and electrical charges to segregate the exRNA carriers. The unique feature here is that each type of carrier has its own "isoelectric point," a particular pH level at which it has no positive or negative charge. Within the device, there's a seemingly simple stream of water flowing. But this stream is special. On the left side, the water is highly acidic, similar to grapefruit juice. On the opposite end of the stream, the water is extremely basic, with a pH similar to a bottle of ammonia. What's particularly remarkable about the device is its ability to generate this pH gradient in the stream without adding any chemicals, making it cost-effective and eco-friendly.

This gradient is made possible by a two-sided membrane that's powered by a custom-designed chip. This membrane divides the water into two types of ions: acidic hydronium ions and basic hydroxide ions, adding a different kind of ion to each side of the stream. As these acidic and basic streams converge, they form a pH gradient, much like how hot and cold streams form hot and cold sides with a gradient of temperature through the middle of the stream. The researchers ran the two devices in parallel and utilized machine learning to select the ideal pH range needed for separating the carriers.

What sets this approach apart is its effectiveness of the pH gradient in segregating the exRNA carriers floating in the stream. When they pass through the pH gradient, the different types of carriers form lines along their isoelectric points, making it easy to channel them into separate outlets. The researchers could obtain incredibly pure samples—up to 97%—using less than a milliliter of body fluids like blood plasma, saliva, or urine. Moreover, while the best current technologies take around a day to separate samples, this new device accomplished the task in just 30 minutes.

“Noncommunicable diseases are responsible for more than 70 percent of deaths worldwide, and cardiovascular disease and cancer are responsible for most of that number,” said postdoctoral fellow Himani Sharma who served as project lead. “Our technology shows a path to improving the way clinicians diagnose these diseases, and that could save a tremendous number of lives.”

Related Links:
University of Notre Dame

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

When dermatologists spot an unusual mark on a patient's skin, they face a choice: monitor it for some time or remove it for biopsy. Similarly, when removing breast tumors, surgeons must send excised tissues... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.